| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 11,945 | 30,421 | ||
| Prepaid expenses and other current assets | 19,709 | 4,090 | ||
| Total current assets | 31,654 | 34,511 | ||
| Security deposits | 252 | 252 | ||
| Operating lease right-of-use asset | 2,468 | 2,579 | ||
| Total assets | 34,374 | 37,342 | ||
| Current portion of operating lease liabilities | 467 | 447 | ||
| Accounts payable | 4,800 | 4,861 | ||
| Accrued expenses and other current liabilities | 23,493 | 10,668 | ||
| Warrant liabilities | 4,142 | 1,773 | ||
| Total current liabilities | 32,902 | 17,749 | ||
| Noncurrent portion of operating lease liabilities | 2,033 | 2,155 | ||
| Total noncurrent liabilities | 2,033 | 2,155 | ||
| Total liabilities | 34,935 | 19,904 | ||
| Common stock, 0.0001 par value 250,000,000 shares authorized as of september 30, 2025 and december 31, 2024 144,300,674 shares issued and outstanding as of september 30, 2025 and 137,228,741 shares issued and outstanding as of december 31, 2024 | 35 | 35 | ||
| Additional paid-in capital | 635,759 | 634,768 | ||
| Accumulated deficit | -636,355 | -617,365 | ||
| Total stockholders' (deficit) equity | -561 | 17,438 | ||
| Total liabilities and stockholders' (deficit) equity | 34,374 | 37,342 | ||
Applied Therapeutics, Inc. (APLT)
Applied Therapeutics, Inc. (APLT)